Terminated PHASE2 INTERVENTIONAL 2-arm NCT01982760

DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty

A Prospective Randomized Trial for the Use of DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty.

Sponsor: University Hospitals Cleveland Medical Center

Interventions DDAVP

Updated 7 times since 2017 Last updated: Jul 26, 2023 Started: Dec 31, 2013 Primary completion: Jun 25, 2015 Completion: Jun 25, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from University Hospitals Cleveland Medical Center

See all terminations from University Hospitals Cleveland Medical Center

This PHASE2 trial investigates Postoperative Ecchymosis and is currently terminated or withdrawn. University Hospitals Cleveland Medical Center leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Sep 2023 — Jul 2024 [monthly]

Terminated PHASE2

Status: Unknown Status → Terminated
Jan 2021 — Sep 2023 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE2
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE2

First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospitals Cleveland Medical Center

Data source: University Hospitals Cleveland Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lyndhurst, United States